Chemical Market Reporter - Eli Lilly bets on Alimta. (Markets: Life Sciences).(
Posted on Monday, June 10 @ 07:00:00 CDT by admin
June 10, 2002 -- ELI LILLY and Company reported positive Phase III trial data on Alimta (pemetrexed) in mesothelioma. Billed as a successor to its flagship oncology ...
Click Here to read the entire article...
|
| |
|